[vc_row][vc_column][vc_column_text]
Pre-Conference Day
Wednesday May 27, 2020
08:00 – 16:45
Palais des Congrès de Paris
Room: TBD
Access for Pre-Conference Day tracks are valid with a Pre-Conference or Conference Bundle registration.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][vc_column_text]Needle to Needle: Cell Processing from Collection to Patient Infusion
Join the journey from ‘Needle to Needle’ as the 2020 Cell Processing Track features a carefully curated program offering a unique look into the production of cell-based products, with a focus on novel processing techniques including gene editing, cell activation and expansion and characterization by flow cytometry. This practical workshop will provide delegates an opportunity to dig into the details of what it takes to bring a product from bench to bedside.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Gold Sponsors
[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Supporting Organization
[/vc_column_text][vc_empty_space height=”15″][vc_column_text][/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Program
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Session 1: Collection and Starting Materials
Jennifer Webb, MD, MSCE, Children’s National Medical Center, United States
Alexey Bersenev, MD, PhD, Yale University, United States
Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute, United States
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”15″][vc_column_text]
Session 2: Selection of Cells and Gene Editing
Ruud Hulspas, PhD, Cellular Technologies Bioconsulting, LLC, Netherlands
Isabelle Riviere, PhD, Memorial Sloan Kettering Cancer Centre, United States
Denise Gavin, PhD, FDA, United States
[/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Lunch Presentations
Beckman Coulter
Be The Match BioTherapies
[/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Session 3: Cell Activation and Expansion
Alex Cheung, PhD, Immulus, Inc., United States
Shabnum Patel, PhD, Stanford University, United States
Maxime Feyeux, PhD, TreeFrog Therapeutics, France
[/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Session 4: ISCT-ISAC Joint Session: Product Characterization
Virginia Litwin, PhD, Caprion Biosciences, Canada
Dianne Kadidlo, MT(ASCP)SBB, University of Minnesota, United States
Andrew Fesnak, MD, University of Pennsylvania, United States
[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Organizing Committee
[/vc_column_text][vc_empty_space height=”15″][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text]Ruud Hulspas, PhD
Cellular Technologies Bioconsulting, LLC
Netherlands[/vc_column_text][vc_empty_space][/vc_column][vc_column width=”1/2″][vc_column_text]Mara Neal, SH(ASCP)MT, MS, MBA
Cook Biotech
United States[/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text]Vicki Antonenas, MSc
Westmead Hospital
Australia[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]Paul Wallace, PhD
Roswell Park Comprehensive Cancer Center
United States[/vc_column_text][/vc_column][/vc_row]